mebendazole has been researched along with Cancer of Gastrointestinal Tract in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " No severe adverse effects were observed." | 3.01 | A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer. ( Alvfors, C; Fryknäs, M; Larsson, R; Loskog, A; Mansoori, S; Nygren, P, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mansoori, S | 1 |
| Fryknäs, M | 1 |
| Alvfors, C | 1 |
| Loskog, A | 1 |
| Larsson, R | 1 |
| Nygren, P | 1 |
1 trial available for mebendazole and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Female; Gastrointestinal Neoplasms; Humans; Male; Mebendazole; M | 2021 |